Lotte Biologics Co. will raise 277.2 billion won ($210 million) via a rights offering, with all proceeds dedicated to constructing its first plant at the Incheon Songdo Bio Campus.
#YonhapInfomax #LotteBiologics #RightsOffering #SongdoBioCampus #CapitalIncrease #PlantConstruction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94893
#YonhapInfomax #LotteBiologics #RightsOffering #SongdoBioCampus #CapitalIncrease #PlantConstruction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94893
Lotte Biologics to Raise 277.2 Billion Won in Rights Offering—Entire Proceeds Allocated to Songdo Plant 1 Construction
Lotte Biologics Co. will raise 277.2 billion won ($210 million) via a rights offering, with all proceeds dedicated to constructing its first plant at the Incheon Songdo Bio Campus.